Publisher
Springer International Publishing
Reference5 articles.
1. Ando, S., Sarlis, N. J., Krishnan, J., Feng, X., Refetoff, S., Zhang, M. Q., et al. (2001). Aberrant alternative splicing of thyroid hormone receptor in a TSH- secreting pituitary tumor is a mechanism for hormone resistance. Molecular Endocrinology, 15, 1529–1538.
2. AFIP atlas of tumor pathology, series 5;SL Asa,2020
3. Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R. C., & Weintraub, B. D. (1996). Thyrotropin-secreting pituitary tumors. Endocrine Reviews, 17, 610–638.
4. Comi, R. J., Gesundheit, N., Murray, L., Gorden, P., & Weintraub, B. D. (1987). Response of thyrotropin-secreting pituitary adenomas to a long- acting somatostatin analogue. The New England Journal of Medicine, 317, 12–17.
5. Foppiani, L., Del, M. P., Ruelle, A., Bandelloni, R., Quilici, P., & Bernasconi, D. (2007). TSH-secreting adenomas: Rare pituitary tumors with multifaceted clinical and biological features. Journal of Endocrinological Investigation, 30, 603–609.